Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-26
1993-06-22
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 19, 546 20, A61K 31445, C07D47110, C07D49810
Patent
active
052216756
ABSTRACT:
Aza-spirocyclic compounds of formula (I) ##STR1## which enhance cortical cholinergic neurotransmission.
REFERENCES:
patent: 5039804 (1991-08-01), Feldman et al.
Heykants et al, Chemical Abstracts, vol. 71 (1969) 122186b.
Chung John Y. L.
Garvey David S.
Abbott Laboratories
Elder Richard A.
Raymond Richard L.
Vadnere Madhavi K.
Weinstock Steven F.
LandOfFree
Aza-spirocyclic compounds that enhance cholinergic neurotransmis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aza-spirocyclic compounds that enhance cholinergic neurotransmis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-spirocyclic compounds that enhance cholinergic neurotransmis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441162